30.71
price down icon0.07%   -0.02
after-market Handel nachbörslich: 30.71
loading

Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten

pulisher
03:58 AM

TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by Entropy Technologies LP - MarketBeat

03:58 AM
pulisher
Feb 13, 2025

Bleakley Financial Group LLC Purchases Shares of 8,140 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Feb 13, 2025
pulisher
Feb 13, 2025

TG Therapeutics to use MaxCyte's Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of autoimmune diseases - MSN

Feb 13, 2025
pulisher
Feb 12, 2025

TG Therapeutics Licenses Maxcyte Tech to Develop Cell Therapies for Autoimmune Disease - Genetic Engineering & Biotechnology News

Feb 12, 2025
pulisher
Feb 12, 2025

46,655 Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) Bought by Strategic Financial Concepts LLC - MarketBeat

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Signs Licensing Deal With TG Therapeutics For Next-Gen Autoimmune Cell Therapies - Nasdaq

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte signs SPL deal with TG Therapeutics - ShareCast

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Signs Platform License Deal With TG Therapeutics -February 12, 2025 at 05:07 am EST - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapeutics programs - MSN

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte, TG Therapeutics sign strategic platform license to advance autoimmune cell therapies - Seeking Alpha

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Partners with TG Therapeutics for Autoimmune Cell Therapy - TipRanks

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs - The Manila Times

Feb 12, 2025
pulisher
Feb 12, 2025

Maxcyte Says Enters Strategic Platform License With TG Therapeutics -February 12, 2025 at 02:18 am EST - Marketscreener.com

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Enters Strategic License Agreement with TG Therapeutics for Cell-Based Therapy Development - Nasdaq

Feb 12, 2025
pulisher
Feb 12, 2025

MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell - The Bakersfield Californian

Feb 12, 2025
pulisher
Feb 10, 2025

SG Americas Securities LLC Has $233,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Feb 10, 2025
pulisher
Feb 10, 2025

Stratos Wealth Advisors LLC Acquires New Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Feb 10, 2025
pulisher
Feb 08, 2025

Institutional investors are TG Therapeutics, Inc.'s (NASDAQ:TGTX) biggest bettors and were rewarded after last week's US$199m market cap gain - Simply Wall St

Feb 08, 2025
pulisher
Feb 08, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Feb 08, 2025
pulisher
Feb 06, 2025

TGTX March 28th Options Begin Trading - Nasdaq

Feb 06, 2025
pulisher
Feb 06, 2025

Symphony Financial Ltd. Co. Acquires New Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Feb 06, 2025
pulisher
Feb 05, 2025

Precision Wealth Strategies LLC Makes New $530,000 Investment in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

TG Therapeutics (NASDAQ:TGTX) Rating Lowered to "Sell" at StockNews.com - MarketBeat

Feb 04, 2025
pulisher
Jan 30, 2025

Nisa Investment Advisors LLC Buys 2,803 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jan 30, 2025
pulisher
Jan 28, 2025

Trading (TGTX) With Integrated Risk Controls - Stock Traders Daily

Jan 28, 2025
pulisher
Jan 28, 2025

All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy - MSN

Jan 28, 2025
pulisher
Jan 25, 2025

TG Therapeutics (NASDAQ:TGTX) Stock Price Up 6.8%Here's What Happened - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

Why TGTX Stock Is Rallying Today - MSN

Jan 25, 2025
pulisher
Jan 23, 2025

TG Therapeutics: Entering 2025 With Increased Investor Expectations (NASDAQ:TGTX) - Seeking Alpha

Jan 23, 2025
pulisher
Jan 23, 2025

Cantor Fitzgerald Weighs in on TG Therapeutics FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Assenagon Asset Management S.A. Decreases Stock Position in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat

Jan 22, 2025
pulisher
Jan 21, 2025

TG Therapeutics: 2025 Revenues Will Smash Expectations (NASDAQ:TGTX) - Seeking Alpha

Jan 21, 2025
pulisher
Jan 20, 2025

12 Hot Stocks to Buy According to Analysts - Insider Monkey

Jan 20, 2025
pulisher
Jan 20, 2025

Here’s Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX) - Insider Monkey

Jan 20, 2025
pulisher
Jan 18, 2025

TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last? - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

(TGTX) Trading Signals - Stock Traders Daily

Jan 18, 2025
pulisher
Jan 18, 2025

Brookstone Capital Management Acquires 624 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Jan 18, 2025
pulisher
Jan 18, 2025

FY2024 EPS Forecast for TG Therapeutics Increased by Analyst - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

Is TG Therapeutics Inc. (TGTX) Among Tuesday’s Top Gainers? - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

TG Therapeutics FY2024 EPS Forecast Raised by HC Wainwright - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

TG Therapeutics Provides Preliminary Fourth Quarter and Full-Year Financial Results in SEC Filing - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

TG Therapeutics: Cash Positive But Playing Defense (Rating Downgrade) (NASDAQ:TGTX) - Seeking Alpha

Jan 16, 2025
pulisher
Jan 16, 2025

TG Therapeutics FY2025 EPS Forecast Raised by HC Wainwright - MarketBeat

Jan 16, 2025
pulisher
Jan 15, 2025

TG Therapeutics' (TGTX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Jan 15, 2025
pulisher
Jan 15, 2025

TGTX Announces 2024 Preliminary Results, 2025 Goals, Shares Rise - MSN

Jan 15, 2025
pulisher
Jan 15, 2025

Exploring Three High Growth Tech Stocks In The United States - Yahoo Finance

Jan 15, 2025
pulisher
Jan 15, 2025

Have Insiders Sold TG Therapeutics Shares Recently? - Simply Wall St

Jan 15, 2025
pulisher
Jan 15, 2025

Expert Outlook: TG Therapeutics Through The Eyes Of 5 Analysts - Benzinga

Jan 15, 2025
pulisher
Jan 14, 2025

10 Firms Post Impressive Gains on Tuesday - Insider Monkey

Jan 14, 2025
$79.31
price up icon 0.81%
$21.37
price down icon 2.06%
$370.58
price up icon 0.04%
$4.94
price up icon 7.39%
biotechnology ONC
$230.86
price up icon 2.38%
$119.83
price down icon 2.40%
Kapitalisierung:     |  Volumen (24h):